Skip to content
Tuesday, October 3, 2023
Latest:
  • Menarini strengthens its presence in aesthetic dermatology in India
  • Rusan Med’s thought-provoking webinar marks ‘Pain Awareness Month’ with expert insights and innovative solutions
  • A Shift to Non-Combustible Tobacco Devices Results in a Smoking Rate Decline by an Average of 5.2%: Says Expert
  • Eyesafe Introduces the World’s Strongest Blue Light Filtration Technology
  • Inspira™ Technologies Unveils the INSPIRA™ ART Line of Medical Devices at the World’s Largest Extracorporeal Life Support Conference
Healthcare Mumbai

Healthcare Mumbai

Mumbai's leading Healthcare News Portal

  • Mental Health
  • Health-Tech
  • Doctors & Hospitals
  • Labs & Diagnostics
  • Covid-19
  • Authored Articles
  • Press Announcements

Clinical study

ALR Technologies Announces Patent Grant for Predictive A1C and Successful Results from Singapore General Hospital-led Study Med-Devices

ALR Technologies Announces Patent Grant for Predictive A1C and Successful Results from Singapore General Hospital-led Study

September 28, 2023September 28, 2023Ragnhild BergLeave a Comment on ALR Technologies Announces Patent Grant for Predictive A1C and Successful Results from Singapore General Hospital-led Study
Henlius’ Novel Anti-PD-1 mAb HANSIZHUANG (Serplulimab) Approved for the Treatment of ESCC Pharmaceuticals

Henlius’ Novel Anti-PD-1 mAb HANSIZHUANG (Serplulimab) Approved for the Treatment of ESCC

September 26, 2023September 26, 2023Anette NilsenLeave a Comment on Henlius’ Novel Anti-PD-1 mAb HANSIZHUANG (Serplulimab) Approved for the Treatment of ESCC
Interim report from clinical study: ColdZyme significantly reduces rhinovirus viral load and symptoms of sore throat Health-Tech

Interim report from clinical study: ColdZyme significantly reduces rhinovirus viral load and symptoms of sore throat

September 21, 2023September 21, 2023Erik JohansenLeave a Comment on Interim report from clinical study: ColdZyme significantly reduces rhinovirus viral load and symptoms of sore throat
Arjuna Natural’s Turmeric–Frankincense Botanical Blend Relieves Menstrual Pain in Clinical Study Pharmaceuticals

Arjuna Natural’s Turmeric–Frankincense Botanical Blend Relieves Menstrual Pain in Clinical Study

July 31, 2023July 31, 2023Geir LundLeave a Comment on Arjuna Natural’s Turmeric–Frankincense Botanical Blend Relieves Menstrual Pain in Clinical Study
UroMems Announces First-Ever Smart Artificial Urinary Sphincter Implant in a Female Patient Med-Devices

UroMems Announces First-Ever Smart Artificial Urinary Sphincter Implant in a Female Patient

July 21, 2023July 21, 2023Henrik OlsenLeave a Comment on UroMems Announces First-Ever Smart Artificial Urinary Sphincter Implant in a Female Patient
Hansa Biopharma Achieves Enrollment Milestone in Phase 2 Imlifidase Trial for Guillain-Barré Syndrome (GBS) Pharmaceuticals

Hansa Biopharma Achieves Enrollment Milestone in Phase 2 Imlifidase Trial for Guillain-Barré Syndrome (GBS)

March 31, 2023March 31, 2023Staff ReporterLeave a Comment on Hansa Biopharma Achieves Enrollment Milestone in Phase 2 Imlifidase Trial for Guillain-Barré Syndrome (GBS)
Glenmark’s GRC 54276 receives FDA green light for cancer clinical trial Med-Devices

Glenmark’s GRC 54276 receives FDA green light for cancer clinical trial

March 17, 2023March 17, 2023Staff ReporterLeave a Comment on Glenmark’s GRC 54276 receives FDA green light for cancer clinical trial
Pharmactive Black Garlic Extract For Blood Pressure Management Pharmaceuticals

Pharmactive Black Garlic Extract For Blood Pressure Management

February 1, 2022February 1, 2022Staff ReporterLeave a Comment on Pharmactive Black Garlic Extract For Blood Pressure Management
The Himalaya Drug Company shares results of a clinical study that evaluated the role of herbal immunomodulators as an adjuvant treatment in the management of COVID-19 Pharmaceuticals

The Himalaya Drug Company shares results of a clinical study that evaluated the role of herbal immunomodulators as an adjuvant treatment in the management of COVID-19

December 18, 2020December 18, 2020Staff ReporterLeave a Comment on The Himalaya Drug Company shares results of a clinical study that evaluated the role of herbal immunomodulators as an adjuvant treatment in the management of COVID-19
Top Picks
  • Menarini strengthens its presence in aesthetic dermatology in India
  • Rusan Med’s thought-provoking webinar marks ‘Pain Awareness Month’ with expert insights and innovative solutions
  • A Shift to Non-Combustible Tobacco Devices Results in a Smoking Rate Decline by an Average of 5.2%: Says Expert
  • Eyesafe Introduces the World’s Strongest Blue Light Filtration Technology
  • Inspira™ Technologies Unveils the INSPIRA™ ART Line of Medical Devices at the World’s Largest Extracorporeal Life Support Conference
  • Akebia Therapeutics Resubmits New Drug Application to the FDA for Vadadustat
  • ALR Technologies Announces Patent Grant for Predictive A1C and Successful Results from Singapore General Hospital-led Study
  • Insights From HumanFirst Show Breadth of Pharmaceutical Investment in AI/ML and Digital Endpoints in Clinical Trials
Powered By: WordPress | Theme: MagazineBook By OdieThemes
Copyright © 2023 Healthcare Mumbai. All Rights Reserved | Powered by Trade News Network (A division of Thought Process Communications LLP)

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Healthcare Mumbai
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.